Clinical Trial Update: Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation [NA]

View source ↗

Summary

This clinical trial update indicates tirzepatide is being studied to reduce recurrence and burden of atrial fibrillation after ablation, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Atrial Fibrillation Ablation, Persistent Atrial Fibrillation | NA | Status: NOT_YET_RECRUITING